Current Opinion in Drug Discovery & Development | Most viewed articles in past 30 days

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central

Quick Search

	Current Opinion in Drug Discovery & Development
	BioMed Central
	PubMed Central
	PubMed

Jump to article


vol.	page no.

Current Opinion in Drug Discovery & Development

Most viewed

Current Opinion in Drug Discovery & Development: Most viewed articles in past 30 days

[more info]

Figures given indicate the abstract, full text and PDF accesses on BioMed Central for each article, over the last 30 days. All research articles are also available via the PubMed Central archive, so the total number of accesses to each article is significantly higher. Lists of most-viewed articles in the past year and all time most-viewed articles are also available

most viewed articles over the last 30 days from all BioMed Central Journals

1. Accesses 166	Review Small-molecule inhibitors of protein-protein interactions T Berg Current Opinion in Drug Discovery and Development 2008, 11:666-674 (22August2008) [PDF]
2. Accesses 140	Review Antibody therapeutics, antibody engineering, and the merits of protein stability SJ Demarest, SM Glaser Current Opinion in Drug Discovery and Development 2008, 11:675-687 (22August2008) [PDF]
3. Accesses 132	Review mGluR5 antagonists: Discovery, characterization and drug development F Gasparini, G Bilbe, B Gomez-Mancilla, W Spooren Current Opinion in Drug Discovery and Development 2008, 11:655-665 (22August2008) [PDF]
4. Accesses 87	Review Ion channels as potential targets for the treatment of depression NJ Lodge, Y-W Li Current Opinion in Drug Discovery and Development 2008, 11:633-641 (22August2008) [PDF]
5. Accesses 53	Review Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic M Medina, A Castro Current Opinion in Drug Discovery and Development 2008, 11:533-543 (30June2008) [PDF] [PubMed] [Related articles]
6. Accesses 52	Review Fragment-based drug design: Combining philosophy with technology S Bartoli, CI Fincham, D Fattori Current Opinion in Drug Discovery and Development 2007, 10:422-429 (17July2007) [PDF] [PubMed] [Related articles]
7. Accesses 51	Review Development of proteasome inhibitors in oncology and autoimmune diseases MK Bennett, CJ Kirk Current Opinion in Drug Discovery and Development 2008, 11:616-625 (22August2008) [PDF]
8. Accesses 42	Review Noninvasive imaging of receptor function: Signal transduction pathways and physiological readouts M Rudin Current Opinion in Drug Discovery and Development 2008, 11:606-615 (22August2008) [PDF]
9. Accesses 42	Review 5-HT6 receptor antagonists: Prospects for the treatment of cognitive disorders including dementia CN Johnson, M Ahmed, ND Miller Current Opinion in Drug Discovery and Development 2008, 11:642-654 (22August2008) [PDF]
10. Accesses 41	Review Drug-induced hepatotoxicity in humans Marzio D Halegoua-De, VJ Navarro Current Opinion in Drug Discovery and Development 2008, 11:53-59 (20December2007) [PDF] [PubMed] [Related articles]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us